MedTrace Logo

Choroidal Thickness in Glaucoma Patients and Healthy Controls

NCT01293474 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-01-06

No results posted yet for this study

Summary

With the new software tool (EDI, enhanced depth imaging) of the Spectralis® spectral-domain optical coherence tomography (SD-OCT) it is possible to visualize and measure the choroidal thickness. In glaucoma a vascular component is known. Therefore a difference of choroidal thickness in glaucoma patients and healthy controls is proposed.

* Trial with medical device

Conditions

  • Glaucoma Patients and Healthy Controls

Interventions

DEVICE

Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

Measurement of the choroidal thickness with Spectralis® SD-OCT

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Christoph Kniestedt, Ass. Prof., MD · University Hospital Zurich, Ophtalmic Clinic

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293474 on ClinicalTrials.gov